Hospital consumption of antibiotics in 15 European countries: Results of the ESAC retrospective data collection (1997-2002)

Journal of Antimicrobial Chemotherapy

Volumn 58, Issue 1, 2006, Pages 159-167

  Vander Stichele, R H ^a,b   Elseviers, M M ^a   Ferech, M ^a   Blot, S ^a,c   Goossens, Herman ^a,d  

^a UNIVERSITY OF ANTWERP   (Belgium)

^b GHENT UNIVERSITY   (Belgium)

^c GHENT UNIVERSITY HOSPITAL   (Belgium)

^d LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Antibacterial agents; Data collection; Drug utilization; Europe; Factual databases; Hospitals; Microbial drug resistance

Indexed keywords

AMINOGLYCOSIDE ANTIBIOTIC AGENT; AMOXICILLIN; AMOXICILLIN PLUS CLAVULANIC ACID; AMPICILLIN; ANTIBIOTIC AGENT; BETA LACTAMASE INHIBITOR; CARBAPENEM; CEPHALOSPORIN; CHLORAMPHENICOL; COTRIMOXAZOLE; LEVOFLOXACIN; LINCOSAMIDE; MACROLIDE; METHENAMINE; MONOBACTAM; MOXIFLOXACIN; NITROFURANTOIN; PENICILLIN G; POLYPEPTIDE ANTIBIOTIC AGENT; QUINOLINE DERIVED ANTIINFECTIVE AGENT; STREPTOGRAMIN; SULFONAMIDE; TETRACYCLINE DERIVATIVE;

AMBULATORY CARE; ARTICLE; CONTROLLED STUDY; CORRELATION COEFFICIENT; DRUG EXPOSURE; DRUG MARKETING; DRUG USE; EUROPE; FEASIBILITY STUDY; FINLAND; FRANCE; GREECE; HOSPITAL CARE; HOSPITAL UTILIZATION; NORWAY; RELIABILITY; RETROSPECTIVE STUDY; SEASONAL VARIATION; SWEDEN;

ANTI-BACTERIAL AGENTS; DATA COLLECTION; DRUG UTILIZATION; ECONOMICS, HOSPITAL; EUROPE; HOSPITALS; HUMANS; RETROSPECTIVE STUDIES;

EID: 33747876461     PISSN: 03057453     EISSN: 14602091     Source Type: Journal    
DOI: 10.1093/jac/dkl147     Document Type: Article

References (39)

1. Gonzalez A, Bischoff T, Tallent S et al. Antibiotic resistance in the community. J Hosp Infect 2003; 55: 156-7.
2. Vandenesch F, Naimi T, Enright MC et al. Community-acquired methicillin-resistant Staphylococcus aureus carrying Panton-Valentine leukocidin genes: Worldwide emergence. Emerg Infect Dis 2003; 9: 978-84.
3. Blot SI, Vandewoude KH, Hoste EA et al. Outcome and attributable mortality in critically ill patients with bacteremia involving methicillin-susceptible and methicillin-resistant Staphylococcus aureus. Arch Intern Med 2002; 162: 2229-35.
4. Lodise TP, McKinnon PS, Tam VH et al. Clinical outcomes for patients with bacteremia caused by vancomycin-resistant enterococcus in a level 1 trauma center. Clin Infect Dis 2002; 34: 922-9.
5. Harbarth S, Garbino J, Pugin J et al. Inappropriate initial antimicrobial therapy and its effect on survival in a clinical trial of immunomodulating therapy for severe sepsis. Am J Med 2003; 115: 529-35.
6. Kunin CM. Antibiotic armageddon. Clin Infect Dis 1997; 25: 240-1.
7. Swartz MN. Use of antimicrobial agents and drug resistance. N Engl J Med 1997; 337: 491-2.
8. Goossens H, Matus F, Vander Stichele RH et al. Outpatient antibiotic use in Europe and association with resistance: A cross-national database study. Lancet 2005; 365: 579-49.
9. Council Recommendation of 15 November 2001 on the prudent use of antimicrobial agents in human medicine. Official Journal of the European Communities L34 2004; 45: 13-6.
10. Vander Stichele RH, Elseviers M, Ferrech M et al. European surveillance of antimicrobial consumption (ESAC): Data collection and methodological approach. Br J Clin Pharmacol 2004; 58: 419-28.
11. World Health Organization. WHO Collaborating Centre for Drug Statistics and Methodology. http://www.whocc.no/atcddd/ (24 February 2006, date last accessed).
12. Ronning M, Blix HS, Strom H et al. Problems in collecting comparable national drug use data in Europe: The example of antibacterials. Eur J Clin Pharmacol 2003; 58: 843-9.
13. Ansari F. Utilization review of systemic antiinfective agents in a teaching hospital in Tehran, Iran. Eur J Clin Pharmacol 2001; 57: 541-6.
14. Rogues AM, Placet-Thomazeau B, Pameix P et al. Use of antibiotics in hospitals in south-western France. J Hosp Infect 2004; 58: 187-92.
15. Muller-Pebody B, Muscat M, Pelle B et al. Increase and change in pattern of hospital antimicrobial use, Denmark, 1997-2001. J Antimicrob Chemother 2004; 54: 1122-6.
16. Kitzes-Cohen R, Koos D, Levy M. Patterns of systemic antibiotic use in a tertiary hospital in Israel in the years 1998-2000. Int J Clin Pharmacol Ther 2004; 42: 246-52.
17. de With K, Bergner J, Buhner R et al. Antibiotic use in German university hospitals 1998-2000 (Project INTERUNI-II). Int J Antimicrob Agents 2004; 24: 213-8.
18. Blix HS, Hartug S. Hospital usage of antibacterial agents in relation to size and type of hospital and geographical situation. Pharmacoepidemiol Drug Saf 2005; 14: 647-9.
19. Kern WV, de With K, Steib-Bauert M et al. Antibiotic use in non-university regional acute care general hospitals in southwestern Germany, 2001-2002. Infection 2005; 33: 333-9.
20. Filius PM, Liem TB, van der Linden PD et al. An additional measure for quantifying antibiotic use in hospitals. J Antimicrob Chemother 2005; 55: 805-8.
21. Kumana CR, Li KY, Kou M et al. Cephalosporin and aminoglycoside utilization in different parts of the world. J Antimicrob Chemother 1989; 24: 1001-10.
22. Janknegt R, Wijnands WJ, Caprasse M et al. Antimicrobial drug use in hospitals in The Netherlands, Germany and Belgium. Eur J Clin Microbiol Infect Dis 1993; 12: 832-8.
23. Kiivet RA, Dahl ML, Llerena A et al. Antibiotic use in 3 European university hospitals. Scand J Infect Dis 1998; 30: 277-80.
24. Gulbinovic J, Myrback KE, Bytautiene J et al. Marked differences in antibiotic use and resistance between university hospitals in Vilnius, Lithuania, and Huddinge, Sweden. Microb Drug Resist 2001; 7: 383-9.
25. Palcevski G, Ahel V, Vlahovic-Palcevski V et al. Antibiotic use profile at paediatric clinics in two transitional countries. Pharmacoepidemiol Drug Saf 2004; 13: 181-5.
26. Cizman M, Beovic B, Krcmery V et al. Antibiotic policies in Central Eastern Europe. Int J Antimicrob Agents 2004; 24: 199-204.
27. De With K, Schroder H, Meyer E et al. Antibiotic use in Germany and European comparison. Dtsch Med Wochenschr 2004; 129: 1987-92.
28. Westh H, Zinn CS, Rosdahl VT. An international multicenter study of antimicrobial consumption and resistance in Staphylococcus aureus isolates from 15 hospitals in 14 countries. Microb Drug Resist 2004; 10: 169-76.
29. Ufer M, Radosević N, Vogt A et al. Antimicrobial drug use in hospitalised paediatric patients: A cross-national comparison between Germany and Croatia. Pharmacoepidemiol Drug Saf 2005; 14: 735-9.
30. Hensher M, Edwards N, Stokes R. International trends in the provision and utilisation of hospital care. BMJ 1999; 319: 845-8.
31. Curtis C, Marriott J, Langley C. Development of a prescribing indicator for objective quantification of antibiotic usage in secondary care. J Antimicrob Chemother 2004; 54: 529-33.
32. Grave K, Lingaas E, Bangen M et al. Surveillance of the overall consumption of antibacterial drugs in humans, domestic animals and farmed fish in Norway in 1992 and 1996. J Antimicrob Chemother 1999; 43: 243-52.
33. Bruinsma N, Kristinsson KG, Bronzwaer S et al. Trends of penicillin and erythromycin resistance among invasive Streptococcus pneumoniae in Europe. J Antimicrob Chemother 2004; 54: 1045-50.
34. Popova M, Popova P, Guencheva G. Consumption of anti-infective drugs in Bulgaria for the period from 1979 to 1994. Pharm World Sci 1997; 19: 93-100.
35. Mutnick AH, Rhomberg PR, Sader HS et al. Antimicrobial usage and resistance trend relationships from the MYSTIC Programme in North America (1999-2001). J Antimicrob Chemother 2004; 53: 290-6.
36. Mutnick AH, Turner PJ, Jones RN. Emerging antimicrobial resistances among Proteus mirabilis in Europe: Report from the MYSTIC Program (1997-2001). Meropenem Yearly Susceptibility Test Information Collection. J Chemother 2002: 14: 253-8.
37. Turner PJ, Greenhalgh JM, MYSTIC Study Group (Europe). The activity of meropenem and comparators against Acinetobacter strains isolated from European hospitals, 1997-2000. Clin Microbiol Infect 2003; 9: 563-7.
38. Sjostedt S, Levin P, Kager L et al. Hospital and catchment area antibiotic utilization and bacterial sensitivity in primary infections following gastric surgery in Huddinge, Sweden. Eur J Clin Pharmacol 1990; 39: 211-6.
39. Seaton RA, Steinke DT, Phillips G et al. Community antibiotic therapy, hospitalization and subsequent respiratory tract isolation of Haemophilus influenzae resistant to amoxycillin: A nested case-control study. J Antimicrob Chemother 2000; 46: 307-9.